Worldwide Market Reports

Increase in Demand Sales of Targeting RNA Sequencing to Record Stellar Growth During the Forecast Period

The report firstly introduced the Targeting RNA Sequencing basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.


Seattle, WA -- (SBWIRE) -- 11/15/2019 -- Industry Insights
Utilization of this data pool in clinical practices is expected to positively influence the adoption rate in this market. Although a surge in the adoption of this technology has been observed, it is still not widely used in certain developing and emerging economies. Lack of trained personnel and high installation / maintenance costs are expected to limit growth of this market during the forecast period.

Technology Insights
NGS-based methods dominated the market in 2016 and are anticipated to maintain their dominance during the forecast period. Significant success of NGS technology is evident by the continuous increase in number of genome projects that are based on next-generation targeted approaches. In addition, players continue to make investments to develop next-generation targeted methods as they understand their significance. Enrichment seq., exome seq., and amplicon seq. are recognized as major NGS methods.

For More Info Get Free Sample Report Here:

Workflow Insights
The entire sequencing process is broken down into pre-sequencing, sequencing, and data analysis. The sequencing process held a major share in 2016. Major factor responsible for this large share is the gradual evolution of modern sequencers for efficient sequencing of large number of samples, which is certainly due to increasing complexity of genome explorations. Moreover, firms have begun to develop third-generation sequencers, which in turn is expected to aid in revenue generation for this segment.

Application Insights
Drug discovery is anticipated to significantly benefit in the coming years from advent of this technology. Factors that are responsible for spurring the adoption of targeted approach in this segment are creation of diverse datasets for drug discovery, growing emphasis on discovery of potential drug targets, and translation of genomic knowledge into rational drug development process.

Type Insights
RNA-seq is expected to witness significant growth in the coming years owing to the growing use of amplicon RNA-seq technology for various disease detection procedures. Growing need for transcriptome study to evaluate disease states and cellular responses to therapeutics is expected to impel the market growth in the near future.

Various end-use segments in this market are academic research, hospitals & clinics, pharma & biotech entities, and other users. These methods are highly utilized in universities and academic entities for accelerating ongoing research projects. This can be attributed to the large share of academic research segment. Moreover, scholarships offered for NGS-based PhD projects are anticipated to positively influence the progress of this segment.

Regional Insights
Presence of large number of genome centers with installed sequencers can be attributed to the large share of the North American region. Asian countries such as Japan and China are expected to emerge as lucrative revenue source in the coming years. Clinical laboratories in this region are continuously making efforts to meet the standard guidelines established by regulatory agencies for accreditation of NGS platforms.

Competitive Insights
Illumina, Inc.; F. Hoffmann-La Roche Ltd; Agilent Technologies; GATC Biotech Ag; Oxford Nanopore Technologies; Thermo Fisher Scientific, Inc.; DNASTAR Inc.; QIAGEN; BGI; Perkin Elmer, Inc.; Pacific Biosciences of California, Inc.; Bio-Rad Laboratories, Inc.; Integrated DNA Technologies, Inc.; RainDance Technologies, Inc.; PierianDx; Genomatix GmbH; and Macrogen, Inc. are some key participants operating in the space.

Else, Place an Inquire before Purchase:

*If you have any special requirements, please let us know and we will offer you the report as you want.